Superoxide dismutase mimetic nanozymes attenuate cardiac microvascular ischemia–reperfusion injury associated with hyperhomocysteinemia
-
Published:2024-04
Issue:
Volume:486
Page:150177
-
ISSN:1385-8947
-
Container-title:Chemical Engineering Journal
-
language:en
-
Short-container-title:Chemical Engineering Journal
Author:
Ding Lu,
Zhang Shifei,
Li YaoORCID,
Wu Yuhao,
Liu Xiaoming,
Xu Dunwu,
Zhao Kaiyang,
Xu Chuan,
Yu Bentong,
Huang XiaolinORCID,
Tang Ben Zhong,
Zhang WanORCID
Funder
Nanchang University
Reference62 articles.
1. Epidemiological studies of CHD and the evolution of preventive cardiology;Wong;Nat. Rev. Cardiol.,2014
2. Recent advances in nanomedicines for imaging and therapy of myocardial ischemia-reperfusion injury;Wang;J. Control. Release.,2023
3. SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways;Ma;Theranostics.,2022
4. H. Zhou, D. Li, P. Zhu, Q. Ma, S. Toan, J. Wang, S. Hu, Y. Chen, Y. Zhang, Inhibitory effect of melatonin on necroptosis via repressing the Ripk3-PGAM5-CypD-mPTP pathway attenuates cardiac microvascular ischemia-reperfusion injury, J. Pineal Res. 65 (2018) e12503, doi: 10.1111/jpi.12503.
5. New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury;Wang;Angiogenesis.,2020